Skip to main content
logo
Biocure Technology Inc. (CSE:CURE.X)
Canada flag Canada · Delayed Price · Currency is CAD
0.0550
0.00 (0.00%)
At close: Aug 13, 2026

Biocure Technology Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-0.3-0.06-0.32-1.05-0.67-1.73
Net Income
-2.3-0.1-0.26-1.81-1.45-1.13
Earnings Per Share
-0.11-0.01-0.03-0.18-0.12-0.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
00.040.0200.040.16
Total Debt
0.060.060.050.040.083.79
Net Cash (Debt)
-0.06-0.02-0.03-0.04-0.04-3.63
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.00-0.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.05-0.080.01-0.22-0.83-1.08
Capital Expenditures
------
Free Cash Flow
-0.05-0.080.01-0.22-0.83-1.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--11.42---